Results 231 to 240 of about 123,443 (349)

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin

, 2008
R. Pertwee
semanticscholar   +1 more source

Long term exposure to dietary cannabinoids inhibits rapid functional tolerance to ethanol in <i>Drosophila melanogaster</i> adults. [PDF]

MicroPubl Biol
Vidal A, Illescas S, Le V, Feldhorn N, Khan S, Loza-Coll M.   +5 more
europepmc   +1 more source

Binding Site Characterization of AM1336, a Novel Covalent Inverse Agonist at Human Cannabinoid 2 Receptor, Using Mass Spectrometric Analysis

, 2017
Srikrishnan Mallipeddi, Simion Kreimer, Nikolai Zvonok, Kiran Vemuri, Barry L. Karger, Alexander R. Ivanov, Alexandros Makriyannis   +6 more
openalex   +2 more sources

Molecular signaling of synthetic cannabinoids: Comparison of CB1 receptor and TRPV1 channel activation

, 2021
Haley K. Andersen, Kenneth B. Walsh
openalex   +2 more sources

Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective

Neuropsychopharmacology, 2018
Z. Cooper, R. Craft
semanticscholar   +1 more source

Cannabidiol in autism: Clinical pharmacology priorities for trial design

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 357-359, February 2026.
Gislei Frota Aragão, Carla Barbosa Brandão, José Evaldo Leandro Júnior   +2 more
wiley   +1 more source

Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP‐43 Mouse Model of Frontotemporal Dementia

The FASEB Journal, Volume 40, Issue 2, 31 January 2026.
TDP‐43 overexpressing mice, a genetic model of frontotemporal dementia, exhibit dramatic changes in their small intestinal endocannabinoidome members, in terms of both altered concentrations of lipid mediators and expression of some of their receptors (Cnr1, Gpr119, Gpr55, Pparg) and metabolic enzymes (Napepld, Faah). Also, the levels of some oxylipins
Hayatte‐Dounia Mir, Giada Giorgini, Irene Santos‐García, Elizabeth Dumais, Carmen Rodríguez‐Cueto, Eva de Lago, Cristoforo Silvestri, Nicolas Flamand, Javier Fernández‐Ruiz, Vincenzo Di Marzo   +9 more
wiley   +1 more source

Advancing cervical cancer treatment: integrating cannabinoids, combination therapies and nanotechnology. [PDF]

J Cancer Res Clin Oncol
Mathibela SP, Ncube KN, Lebelo MT, Steenkamp V.   +3 more
europepmc   +1 more source

The reasons for use of cannabinoids and stimulants in patients with schizophrenia

, 2018
Katarzyna Simonienko, Natalia Wygnał, Urszula Cwalina, Mikołaj Kwiatkowski, Agata Szulc, Napoleon Waszkiewicz   +5 more
openalex   +1 more source

CYP4X1/sEH‐Dependent Endocannabinoid Metabolism Drives Fibroblast‐Mediated Immunosuppression to Limit Immunotherapy in Colon Cancer

Advanced Science, Volume 13, Issue 5, 27 January 2026.
A proposed mechanism to explain the role of CYP4X1/sEH‐14,15‐EET‐EA system in colon cancer immune escape. 14,15‐EET‐EA, 14,15‐epoxyeicosatrienoic acid‐ethanolamide; sEH, soluble epoxide hydrolase; CYP4X1, cytochrome P450 4X1; GPR119, G‐protein coupled receptor 119; EGFR, epidermal growth factor receptor; Gs, Gαs subunit; cAMP, cyclic adenosine ...
Min Mo, Xuewei Chen, Yanzhuo Liu, Chenlong Wang, Xuehan Chen, Nan Zhang, Nan He, Ying Li, Jingyi Wang, Honglei Chen, Jing Yang   +10 more
wiley   +1 more source